Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > You boys Dream Small.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(117)
•••
Comment by gojotv!on Mar 03, 2021 5:41pm
230 Views
Post# 32710958

RE:RE:You boys Dream Small.

RE:RE:You boys Dream Small.See, this is where I get that the American Trumpers are just soft bashers trying to muscle in to Canadian tech and bring it to America... CHEAP!
Why wouldn't TLT go from $0.20 to $20.00?
I bought PYR at $0.37 and withint the year it went to $15.00+!
Considering that that's still a developing company and that this is THE CURE FOR TUMEROUS CANCERS, I'm thinking the shares should be at $200.00 within three, four years.
And I am not selling that away for $4.00.
Not today, Satan.
Not ever.
But it's nice to know who's behind this manipulation keeping the price down and working hard to make friends on this board since Trump lost so decisively in the last election...
We see you.

StevenBirch wrote: A buyout wouldn't be for pittance. I agree with Eoganacht that 2022 would be the time frame because as Laser once said we won't go from 20 cents to 20 dollars. And I think this is the year we get the decimal moved over and he always had it valued around $4 give or take. Then that is the time period where anyone who wanted to buy the company would have to try and put a value on it.

I don't envy them THAT task but I don't care if there are enough o's after it and I don't care about dividends - we don't need no stinking dividends!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities